Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis

scientific article

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814
systematic reviewQ1504425
review articleQ7318358

External links are
P819ADS bibcode2013PLoSO...868152P
P356DOI10.1371/JOURNAL.PONE.0068152
P932PMC publication ID3707972
P698PubMed publication ID23874527
P5875ResearchGate publication ID250925812

P50authorReto NüeschQ41653968
Thomas ReibergerQ42987335
Deenan PillayQ57899870
Richard GilsonQ62006744
Firouzé Bani-SadrQ88947273
Marina NunezQ89643739
David T DunnQ91490016
Christoph StephanQ96206968
Mamta K JainQ98936517
Marion G PetersQ104074133
Stefan MaussQ114739524
Huw PriceQ117791924
Theodora de Vries-SluijsQ117792002
Noriyoshi KuzushitaQ117792037
Lionel TanQ117792401
P2860cites workPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQ21562278
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsQ28375088
Predictors of loss of hepatitis B surface antigen in HIV-infected patientsQ33716290
Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week DataQ33799094
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.Q33968358
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.Q34621209
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected PatientsQ35200503
Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patientsQ37149701
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.Q39375453
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strainsQ39876916
In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agentsQ40115548
Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virusQ40262602
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infectionQ41604155
Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in ThailandQ42909958
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virusQ42923518
Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.Q42989166
Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virusQ43906148
Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohortQ43972819
Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virusQ44583350
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudineQ45397952
Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infectionQ45398562
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D studyQ45413375
Tenofovir for chronic hepatitis B virus infection in HIV-coinfected patients.Q45417636
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virusQ45422795
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.Q45423363
Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir.Q46003766
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.Q46217486
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.Q46243261
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in ThailandQ46433832
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.Q46644424
Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen.Q54571805
British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010Q57180947
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfectionQ57271233
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort studyQ58097173
Hepatitis B Surface Antigen Declines and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIVQ58376622
Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with responseQ58646483
Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analoguesQ82451832
Longer duration of HBV-active antiretroviral therapy is linked to favorable virological outcome in HIV-HBV co-infected patientsQ84293502
Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovirQ84868978
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectHepatitis B virusQ6844
hepatitis BQ6853
adenineQ15277
tenofovirQ155954
human immunodeficiency virus infectious diseaseQ18556697
coinfectionQ1243018
anti-HIV agentsQ50377208
organophosphonateQ76636048
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)e68152
P577publication date2013-07-10
P1433published inPLOS OneQ564954
P1476titleSuppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis
P478volume8